Our mission is to develop and use advanced imaging for individualised therapy to improve public health. To this end we focus on addressing key diagnostic challenges in clinical practice.
In neurosciences we are developing endophenotypes and biomarkers to allow early diagnosis, to predict natural history risk, and to assess therapeutic responses. We study patients from a range of diseases (stroke, neurodegeneration, brain cancer, mental health disorders, chronic pain), but adopt a symptom and outcome based rather than disease-specific approach.
In oncology we are developing novel markers and probes for use in MRI, SPECT and PET, translating discovery from preclinical evaluation to clinical implementation.
In gastroenterology we are working on methods for measuring transit and motility linking with the Nottingham Digestive Diseases BRU.
Research projects are early to late translational and transdisciplinary using latest knowledge in imaging sciences to discover, qualify and validate imaging markers.
The Division works closely with clinicians and healthcare scientists within Nottingham University Hospitals NHS Trust, neuroscientists and MR physicists from within the School of Clinical Sciences and the Sir Peter Mansfield Magnetic Resonance Centre and is a member of the ARC Pain Centre.
We offer an active postgraduate training programme to PhD level for clinicians and scientists including a taught MSc Course in Translational Neuroimaging.
--Dorothee Auer, Head of Division